CN103830636A - Pharmaceutical composition for treating bronchitis and asthma - Google Patents

Pharmaceutical composition for treating bronchitis and asthma Download PDF

Info

Publication number
CN103830636A
CN103830636A CN201410003045.4A CN201410003045A CN103830636A CN 103830636 A CN103830636 A CN 103830636A CN 201410003045 A CN201410003045 A CN 201410003045A CN 103830636 A CN103830636 A CN 103830636A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
radix
herba
lagotis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410003045.4A
Other languages
Chinese (zh)
Inventor
曹荣荣
崔磊
石瑛
金福娥
Original Assignee
崔磊
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 崔磊 filed Critical 崔磊
Priority to CN201410003045.4A priority Critical patent/CN103830636A/en
Publication of CN103830636A publication Critical patent/CN103830636A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a pharmaceutical composition for treating bronchitis and asthma. The pharmaceutical composition is prepared from the following components by weight: 40 to 60 parts of aster root, 40 to 60 parts of dandelion, 25 to 35 parts of stemona root, 25 to 35 parts of anemarrhena, 20 to 30 parts of tendrilleaf fritillary bulb, 10 to 20 parts of ephedra stem, 10 to 20 parts of common andrographis herb, 10 to 20 parts of isatis root, 3 to 8 parts of LagotisclarkeiHook.F., 3 to 8 parts of borneol and 3 to 8 parts of dwarf lilyturf root. The ministerial drugs of the pharmaceutical composition are capable of clearing heat, removing toxins, eliminating phlegm, dissipating binds, generating body fluid and moisturizing dryness, thereby eliminating inflammations of bronchi and the lung, and capable of tonifying the spleen and the kidney, thereby eliminating the symptom of difficulty in breathing; the adjuvant and conductant drugs are used for maintenance and protection of the respiratory system and for basis consolidation; drugs of the pharmaceutical composition are compatible and synergistic, so inflammations are eliminated, and the adjuvant and conductant drugs are cooperatively used for alleviation of toxicity and virulence of drugs; and the pharmaceutical composition is used for treating a series of symptoms caused by bronchitis and asthma.

Description

A kind of pharmaceutical composition for the treatment of bronchitis asthma
Technical field
The present invention relates to the medication of a kind of Respiratory Medicine common disease, particularly a kind of pharmaceutical composition for the treatment of bronchitis asthma.
Background technology
Bronchial asthma, also claims asthma conventionally.Clinical manifestation is: patient respiratory difficulty, rapid, often with nasopharynx itch, dry cough, uncomfortable in chest, cyanosis of the face and lips, opening mouth and lifting shoulder due to dyspnea, breast has toot sound, volume antiperspirant is difficult sleeping, outbreak repeatedly, continue at every turn a few minutes, several hours even several days not etc., taking night and morning as many.Severe one is with increased heart rate, paradoxical pulse, breast abdomen dyskinesis and cyanosis phenomenon.The cause of disease and the pathogenesis of asthma imperfectly understand, and Therapeutic Method and medicine are different, and determined curative effect, the medicine that particularly can cure still lacks very much.In the last few years, foreign study adopted aminophylline, cut sieve treatment bronchial asthma, and the curative effect of just taking is better, then patient body strengthens Western medicine Drug resistance, to the chronic disease of this frequent anti-slander, need to strengthen dose, to reach therapeutic effect, and the Drug resistance due to patient having, also be difficult to find out effect even if strengthen dose, meanwhile, the toxic and side effects of these medicines is larger, complication is many, makes numerous often ill weak patients be difficult to take; In addition, Western medicine is cured the symptoms, not the disease conventionally, and the duration of drug effect is short.Also there are clinically patient's Chinese medicine and western medicine clothes of holding concurrently, but still have the drawback of the large and effect relative mistake of dose.
Summary of the invention
The technical problem to be solved in the present invention is the above-mentioned defect that how to overcome prior art, and a kind of pharmaceutical composition for the treatment of bronchitis asthma is provided.
For solving the problems of the technologies described above, the pharmaceutical composition of this treatment bronchitis asthma by following component according to shown in weight ratio scope prepare, 40~60 parts of Radix Asteriss, 40~60 parts of Herba Taraxacis, 25~35 parts of the Radixs Stemonae, 25~35 parts of the Rhizoma Anemarrhenaes, 20~30 parts of Bulbus Fritillariae Cirrhosaes, 10~20 parts, Herba Ephedrae, 10~20 parts of Herba Andrographis, 10~20 parts of Radix Isatidis, 3~8 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 3~8 parts of Borneolum Syntheticums, 3~8 parts of Radix Ophiopogonis.
As optimum ratio scope, described pharmaceutical composition by following component according to shown in weight ratio scope prepare, 49~51 parts of Radix Asteriss, 49~51 parts of Herba Taraxacis, 29~31 parts of the Radixs Stemonae, 29~31 parts of the Rhizoma Anemarrhenaes, 29~31 parts of Bulbus Fritillariae Cirrhosaes, 14~16 parts, Herba Ephedrae, 14~16 parts of Herba Andrographis, 14~16 parts of Radix Isatidis, 5~7 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 5~7 parts of Borneolum Syntheticums, 5~7 parts of Radix Ophiopogonis.
As optimum ratio, described pharmaceutical composition by following component according to shown in weight ratio prepare, 60 parts of Radix Asteriss, 40 parts of Herba Taraxacis, 35 parts of the Radixs Stemonae, 25 parts of the Rhizoma Anemarrhenaes, 30 parts of Bulbus Fritillariae Cirrhosaes, 10 parts, Herba Ephedrae, 20 parts of Herba Andrographis, 10 parts of Radix Isatidis, 8 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 3 parts of Borneolum Syntheticums, 8 parts of Radix Ophiopogonis.
As optimum ratio, described pharmaceutical composition by following component according to shown in weight ratio prepare, 40 parts of Radix Asteriss, 60 parts of Herba Taraxacis, 25 parts of the Radixs Stemonae, 35 parts of the Rhizoma Anemarrhenaes, 20 parts of Bulbus Fritillariae Cirrhosaes, 20 parts, Herba Ephedrae, 10 parts of Herba Andrographis, 20 parts of Radix Isatidis, 3 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 8 parts of Borneolum Syntheticums, 3 parts of Radix Ophiopogonis.
As further optimum ratio, described pharmaceutical composition by following component according to shown in weight ratio prepare, 51 parts of Radix Asteriss, 49 parts of Herba Taraxacis, 31 parts of the Radixs Stemonae, 29 parts of the Rhizoma Anemarrhenaes, 31 parts of Bulbus Fritillariae Cirrhosaes, 14 parts, Herba Ephedrae, 16 parts of Herba Andrographis, 14 parts of Radix Isatidis, 7 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 5 parts of Borneolum Syntheticums, 7 parts of Radix Ophiopogonis.
As further optimum ratio, described pharmaceutical composition by following component according to shown in weight ratio prepare, 49 parts of Radix Asteriss, 51 parts of Herba Taraxacis, 29 parts of the Radixs Stemonae, 31 parts of the Rhizoma Anemarrhenaes, 29 parts of Bulbus Fritillariae Cirrhosaes, 16 parts, Herba Ephedrae, 146 parts of Herba Andrographis, 16 parts of Radix Isatidis, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 7 parts of Borneolum Syntheticums, 5 parts of Radix Ophiopogonis.
As best proportioning, described pharmaceutical composition by following component according to shown in weight ratio prepare, 50 parts of Radix Asteriss, 50 parts of Herba Taraxacis, 30 parts of the Radixs Stemonae, 30 parts of the Rhizoma Anemarrhenaes, 30 parts of Bulbus Fritillariae Cirrhosaes, 15 parts, Herba Ephedrae, 15 parts of Herba Andrographis, 15 parts of Radix Isatidis, 6 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 6 parts of Borneolum Syntheticums, 6 parts of Radix Ophiopogonis.
The pharmaceutical composition of this treatment bronchitis asthma is coated tablet, its preparation method is, by Radix Asteris, Herba Taraxaci, the Radix Stemonae, the Rhizoma Anemarrhenae, Bulbus Fritillariae Cirrhosae, Herba Ephedrae, Herba Andrographis, Radix Isatidis, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), Borneolum Syntheticum, after weighing by described proportioning Radix Ophiopogonis, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug.
Pharmacology analysis
Radix Asteris: bitter in the mouth, pungent, slightly warm in nature; Dissipating phlegm and keeping the adverse QI downwards, lung heat clearing expel the heat-evil, regulating fluid apssage.
Herba Taraxaci: bitter in the mouth, sweet, cold in nature; Return liver, stomach warp; Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome, for furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.
The Radix Stemonae: sweet in the mouth, hardship, slightly warm in nature; Return lung meridian; Nourishing the lung to keep the adverse QI downward cough-relieving, parasite killing, coughs for new chronic cough, lung impairment and cough, pertussis; Outward for head louse, body louse, enterobiasis, pudendal pruritus disease, sweet Radix Stemonae nourishing the lung to arrest cough, for deficiency of YIN chronic cough.
The Rhizoma Anemarrhenae: bitter in the mouth, sweet, cold in nature; Return lung, stomach, kidney channel; Clearing away heat-fire, promotes the production of body fluid and moisturizes, for fever caused by exogenous pathogenic factors, and high hot excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, dryness of the intestine constipation.
Bulbus Fritillariae Cirrhosae: bitter, sweet, be slightly cold; Return lung, heart channel; Clearing heat and moistening lung, preventing phlegm from forming and stopping coughing; For lung-heat type cough, the few expectorant of dry cough, deficiency of YIN chronic cough, sputum with blood.
Herba Ephedrae: acrid in the mouth, micro-hardship, warm in nature; Diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.For anemofrigid cold, uncomfortable in chestly breath with cough, edema due to wind pathogen edema, bronchial asthma.
Herba Andrographis: bitter in the mouth, cold in nature.GUIXIN, lung, large intestine, urinary bladder channel.Heat-clearing and toxic substances removing, pathogenic fire purging, dampness, clinical in anemopyretic cold, epidemic febrile disease heating, cough due to lung-heat, pertussis, lung abscess, laryngopharynx swelling and pain, jaundice due to damp-heat, stranguria, erysipelas, skin infection carbuncle, eczema, venom etc.
Radix Isatidis: bitter in the mouth, cold in nature; GUIXIN, stomach warp; Heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving, for maculae caused by violent heat pathogen, crimson tongue is purple dark, mumps, sore throat, scarlet fever, major part pestilence, erysipelas, carbuncle.
Lagotis clarkei Hook. F (Lagotis brevituba Maxim.): bitter in the mouth, sweet, cold in nature; Heat-clearing and toxic substances removing; Blood pressure lowering; Regulating menstruation, main acute, chronic hepatitis, nephritis, lung abscess, hypertension, the moon often uncomfortable, breast carcinoma.
Borneolum Syntheticum: acrid in the mouth, hardship, cool in nature; GUIXIN, lung meridian; The refreshment of having one's ideas straightened out, heat radiation pain relieving, improving eyesight removing nebula, for apoplexy, calentura coma, deafness with qi stagnation, sore throat, aphtha, carbuncle, hemorrhoid, the diseases such as enterobiasis.
Radix Ophiopogonis: sweet in the mouth, micro-hardship, cold nature; GUIXIN, lung, stomach warp; YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire, for dryness of the lung dry cough, chronic consumptive disease cough, Tianjin wound is thirsty, vexed insomnia, interior-heat is quenched one's thirst, dryness of the intestine constipation, pharyngeal diphtheria.
A kind of pharmaceutical composition for the treatment of bronchitis asthma of the present invention is taking Radix Asteris, Herba Taraxaci, Bulbus Fritillariae Cirrhosae, Herba Ephedrae as ministerial drug, heat-clearing and toxic substances removing, expectorant powder junction, promotes the production of body fluid and moisturizes, and eliminates bronchus and pneumonia; Taking the Radix Stemonae, the Rhizoma Anemarrhenae, Herba Andrographis as ministerial drug, invigorating spleen and kidney, helping inspiration to relieve asthma, the symptom of elimination hypopnea; Taking Radix Isatidis, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), Borneolum Syntheticum, Radix Ophiopogonis as adjuvant blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, invigorating the spleen and replenishing QI, nourishing kidney lung moistening, air making-up and spleen enlivening, for maintenance protection and the vital base and primordial QI consolidating of respiratory system; All medicine compatibilities in side, the monarch and his subjects pull together, eliminate the inflammation, assistant makes auxiliary altogether, and the toxicity of cushion and strong is used for the treatment of cough that bronchial asthma causes, pants, the symptom such as dyspnea, uncomfortable in chest, expectoration, the ictal expiratory dyspnea with wheezing sound.
Detailed description of the invention
Embodiment 1: by Radix Asteris 60g, Herba Taraxaci 40g, Radix Stemonae 35g, Rhizoma Anemarrhenae 25g, Bulbus Fritillariae Cirrhosae 30g, Herba Ephedrae 10g, Herba Andrographis 20g, Radix Isatidis 10g, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 8g, Borneolum Syntheticum 3g, Radix Ophiopogonis, the proportioning of 8g took each component, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug, obtain the pharmaceutical composition coated tablet A of this treatment bronchitis asthma.
Embodiment 2: by Radix Asteris 40g, Herba Taraxaci 60g, Radix Stemonae 25g, Rhizoma Anemarrhenae 35g, Bulbus Fritillariae Cirrhosae 20g, Herba Ephedrae 20g, Herba Andrographis 10g, Radix Isatidis 20g, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 3g, Borneolum Syntheticum 8g, Radix Ophiopogonis, the proportioning of 3g took each component, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug, obtain the pharmaceutical composition coated tablet B of this treatment bronchitis asthma.
Embodiment 3: by Radix Asteris 51g, Herba Taraxaci 49g, Radix Stemonae 31g, Rhizoma Anemarrhenae 29g, Bulbus Fritillariae Cirrhosae 31g, Herba Ephedrae 14g, Herba Andrographis 16g, Radix Isatidis 14g, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 7g, Borneolum Syntheticum 5g, Radix Ophiopogonis, the proportioning of 7g took each component, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug, obtain the pharmaceutical composition coated tablet C of this treatment bronchitis asthma.
Embodiment 4: by Radix Asteris 49g, Herba Taraxaci 51g, Radix Stemonae 29g, Rhizoma Anemarrhenae 31g, Bulbus Fritillariae Cirrhosae 29g, Herba Ephedrae 16g, Herba Andrographis 146g, Radix Isatidis 16g, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 5g, Borneolum Syntheticum 7g, Radix Ophiopogonis, the proportioning of 5g took each component, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug, obtain the pharmaceutical composition coated tablet D of this treatment bronchitis asthma.
Embodiment 5: by Radix Asteris 50g, Herba Taraxaci 50g, Radix Stemonae 30g, Rhizoma Anemarrhenae 30g, Bulbus Fritillariae Cirrhosae 30g, Herba Ephedrae 15g, Herba Andrographis 15g, Radix Isatidis 15g, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 6g, Borneolum Syntheticum 6g, Radix Ophiopogonis, the proportioning of 6g took each component, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug, obtain the pharmaceutical composition coated tablet E of this treatment bronchitis asthma.
In above-described embodiment, embodiment 5 is most preferred embodiment of the present invention.
Clinical data
(1) case: 300 routine Bronchial Asthmas are carried out to clinical observation treatment.Wherein male's 200 examples, women's 100 examples, between 25 to 67 years old age, 41 years old mean age, the course of disease 2 to 10 years, average 4.3 years.
(2) Therapeutic Method: pharmaceutical composition coated tablet E every day of this treatment bronchitis asthma prepared by oral embodiment 5 three times, each two.Calculate treatment time according to conditions of patients weight, patients with mild was taken about 20 days, and severe case serve on 90 days and can fully recover.
(3) criterion: healing-symptom all disappears; Main physics and chemistry detects index and is normally; Effective-symptomatology is eliminated or cardinal symptom is eliminated, and physics and chemistry detects index normal; Effectively-cardinal symptom disappears substantially, and main physics and chemistry detects index and makes moderate progress; It is front unchanged with treatment that invalid-main physics and chemistry detects index.
(4) therapeutic effect: clinical cure 240 examples, effective 30 examples, effective 20 examples, invalid 10 examples, all cases all have no adverse reaction.
(5) curative effect is summed up: clinical time 4 to 5 years, curative effect 1 month effectively, the course for the treatment of general patient 4 months, symptom disappears substantially, 6 months diseases of patient with severe symptoms disappear, within 8 months, symptom all disappears.Effective percentage 96.67%, cure rate 80.00%.
Above-mentioned embodiment is intended to illustrate the present invention and can be professional and technical personnel in the field's realization or use; it will be apparent for those skilled in the art that above-mentioned embodiment is modified; therefore the present invention includes but be not limited to above-mentioned embodiment; any these claims or description of meeting described; meet and principle disclosed herein and novelty, the method for inventive features, technique, product, within all falling into protection scope of the present invention.

Claims (8)

1. treat the pharmaceutical composition of bronchitis asthma for one kind, it is characterized in that: this pharmaceutical composition by following component according to shown in weight ratio scope prepare, 40~60 parts of Radix Asteriss, 40~60 parts of Herba Taraxacis, 25~35 parts of the Radixs Stemonae, 25~35 parts of the Rhizoma Anemarrhenaes, 20~30 parts of Bulbus Fritillariae Cirrhosaes, 10~20 parts, Herba Ephedrae, 10~20 parts of Herba Andrographis, 10~20 parts of Radix Isatidis, 3~8 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 3~8 parts of Borneolum Syntheticums, 3~8 parts of Radix Ophiopogonis.
2. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 1, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio scope prepare, 49~51 parts of Radix Asteriss, 49~51 parts of Herba Taraxacis, 29~31 parts of the Radixs Stemonae, 29~31 parts of the Rhizoma Anemarrhenaes, 29~31 parts of Bulbus Fritillariae Cirrhosaes, 14~16 parts, Herba Ephedrae, 14~16 parts of Herba Andrographis, 14~16 parts of Radix Isatidis, 5~7 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 5~7 parts of Borneolum Syntheticums, 5~7 parts of Radix Ophiopogonis.
3. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 1, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio prepare, 60 parts of Radix Asteriss, 40 parts of Herba Taraxacis, 35 parts of the Radixs Stemonae, 25 parts of the Rhizoma Anemarrhenaes, 30 parts of Bulbus Fritillariae Cirrhosaes, 10 parts, Herba Ephedrae, 20 parts of Herba Andrographis, 10 parts of Radix Isatidis, 8 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 3 parts of Borneolum Syntheticums, 8 parts of Radix Ophiopogonis.
4. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 1, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio prepare, 40 parts of Radix Asteriss, 60 parts of Herba Taraxacis, 25 parts of the Radixs Stemonae, 35 parts of the Rhizoma Anemarrhenaes, 20 parts of Bulbus Fritillariae Cirrhosaes, 20 parts, Herba Ephedrae, 10 parts of Herba Andrographis, 20 parts of Radix Isatidis, 3 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 8 parts of Borneolum Syntheticums, 3 parts of Radix Ophiopogonis.
5. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 2, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio prepare, 51 parts of Radix Asteriss, 49 parts of Herba Taraxacis, 31 parts of the Radixs Stemonae, 29 parts of the Rhizoma Anemarrhenaes, 31 parts of Bulbus Fritillariae Cirrhosaes, 14 parts, Herba Ephedrae, 16 parts of Herba Andrographis, 14 parts of Radix Isatidis, 7 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 5 parts of Borneolum Syntheticums, 7 parts of Radix Ophiopogonis.
6. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 2, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio prepare, 49 parts of Radix Asteriss, 51 parts of Herba Taraxacis, 29 parts of the Radixs Stemonae, 31 parts of the Rhizoma Anemarrhenaes, 29 parts of Bulbus Fritillariae Cirrhosaes, 16 parts, Herba Ephedrae, 146 parts of Herba Andrographis, 16 parts of Radix Isatidis, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 7 parts of Borneolum Syntheticums, 5 parts of Radix Ophiopogonis.
7. the pharmaceutical composition for the treatment of bronchitis asthma according to claim 2, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio prepare, 50 parts of Radix Asteriss, 50 parts of Herba Taraxacis, 30 parts of the Radixs Stemonae, 30 parts of the Rhizoma Anemarrhenaes, 30 parts of Bulbus Fritillariae Cirrhosaes, 15 parts, Herba Ephedrae, 15 parts of Herba Andrographis, 15 parts of Radix Isatidis, 6 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 6 parts of Borneolum Syntheticums, 6 parts of Radix Ophiopogonis.
8. according to the pharmaceutical composition of the arbitrary described treatment bronchitis asthma of claim 1 to 7, it is characterized in that: described pharmaceutical composition is coated tablet, its preparation method is, by Radix Asteris, Herba Taraxaci, the Radix Stemonae, the Rhizoma Anemarrhenae, Bulbus Fritillariae Cirrhosae, Herba Ephedrae, Herba Andrographis, Radix Isatidis, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), Borneolum Syntheticum, after weighing by described proportioning Radix Ophiopogonis, the Radix Isatidis decocting liquid that half amount is got is made diluent, the Radix Isatidis of half amount mixes with all the other components in addition, add the water soaking of 10 times of amounts of mixture to decoct three times, each about one hour, the decocting liquid that merges three times filters, and be concentrated into paste, adding Radix Isatidis liquid diluent stirs and makes soft material again, under 40~60 DEG C of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 20 order granules, after granulate, add 1% magnesium stearate of granular mass, be pressed into the every sugar coated tablet containing 1 gram of crude drug.
CN201410003045.4A 2014-01-06 2014-01-06 Pharmaceutical composition for treating bronchitis and asthma Pending CN103830636A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410003045.4A CN103830636A (en) 2014-01-06 2014-01-06 Pharmaceutical composition for treating bronchitis and asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410003045.4A CN103830636A (en) 2014-01-06 2014-01-06 Pharmaceutical composition for treating bronchitis and asthma

Publications (1)

Publication Number Publication Date
CN103830636A true CN103830636A (en) 2014-06-04

Family

ID=50794738

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410003045.4A Pending CN103830636A (en) 2014-01-06 2014-01-06 Pharmaceutical composition for treating bronchitis and asthma

Country Status (1)

Country Link
CN (1) CN103830636A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208402A (en) * 2014-09-03 2014-12-17 青岛市市立医院 Adjuvant asthma rehabilitation agent for pediatric department
CN104248706A (en) * 2014-09-09 2014-12-31 韩先章 Medicine treating chronic bronchitis
CN104288484A (en) * 2014-09-09 2015-01-21 韩先章 Medicament for treating bronchitis and asthma
CN104288545A (en) * 2014-09-09 2015-01-21 韩先章 Medicament for treating emphysema
CN105535680A (en) * 2015-12-31 2016-05-04 刘宝龙 Patent medicine for coping with acute asthma episode in emergency treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1335170A (en) * 2001-07-12 2002-02-13 郑连亚 Trachitis treating Chinese medicine
CN103212006A (en) * 2013-05-20 2013-07-24 李飞 Traditional Chinese medicine for treating chronic bronchitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1335170A (en) * 2001-07-12 2002-02-13 郑连亚 Trachitis treating Chinese medicine
CN103212006A (en) * 2013-05-20 2013-07-24 李飞 Traditional Chinese medicine for treating chronic bronchitis

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208402A (en) * 2014-09-03 2014-12-17 青岛市市立医院 Adjuvant asthma rehabilitation agent for pediatric department
CN104248706A (en) * 2014-09-09 2014-12-31 韩先章 Medicine treating chronic bronchitis
CN104288484A (en) * 2014-09-09 2015-01-21 韩先章 Medicament for treating bronchitis and asthma
CN104288545A (en) * 2014-09-09 2015-01-21 韩先章 Medicament for treating emphysema
CN105535680A (en) * 2015-12-31 2016-05-04 刘宝龙 Patent medicine for coping with acute asthma episode in emergency treatment

Similar Documents

Publication Publication Date Title
CN101693089B (en) Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof
CN101301396A (en) Medicament for treating oral ulcer of children and preparation thereof
CN103830636A (en) Pharmaceutical composition for treating bronchitis and asthma
CN101745060B (en) Chinese medicament for treating chronic bronchitis
CN102085346B (en) Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease
CN101766787B (en) Enema liquid for treating hyperpyrexia and cough and asthma
CN104547496A (en) Traditional Chinese medicine composition for moistening lung to arrest cough and preparation method thereof
CN106138360A (en) A kind of Chinese medicine composition and preparation method thereof, application
CN103028093B (en) Traditional Chinese medicine composition for treating chronic obstructive pulmonary emphysema and preparation method of traditional Chinese medicine composition
CN104288745A (en) Traditional Chinese medicine for treating CG (Chronic Gastritis)
CN102188619A (en) Traditional Chinese medicine for treating radiation pneumonia
CN103495130B (en) Traditional Chinese medicine composition for treating asthma
CN102716372B (en) Traditional Chinese medicine composition for curing chronic cough, and preparation method and usage thereof
CN101618081A (en) Pure traditional Chinese medicine toothache rapid relief gargle and preparation method thereof
CN104147334A (en) Traditional Chinese medicine formula capable of eliminating phlegm
CN102225111B (en) Traditional Chinese medicine granule for treating headache caused by rhinitis and preparation method thereof
CN102727738A (en) Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof
CN107468885A (en) A kind of pill medicine for treating viral respiratory infection and preparation method thereof
CN104288484A (en) Medicament for treating bronchitis and asthma
CN105434533A (en) Traditional Chinese medicine composition for treating liver cancer
CN105168860A (en) Traditional Chinese medicine composite for treating infantile asthma and preparation method thereof
CN101185742A (en) Chinese traditional medicinal composition for treating epilepsy
CN104096148A (en) Traditional Chinese medicine for treating infantile pneumonia
CN104147095A (en) Pediatric expectorant syrup and preparation method thereof
CN104083733A (en) Traditional Chinese medicine preparation for cold-type children's bronchitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140604